D. E. Partridge-Telenko,
D. M. Livingstone,
B. B. Shew,
P. M. Phipps, and
E. A. Grabau
First and fifth authors: Virginia Tech, Tidewater Agricultural Research & Extension Center, Suffolk 23437; second author: Department of Plant Pathology, University of Florida, Gainesville 32611; third author: 9 Scott's Camp Road, Pozieres, Queensland 4352, Australia; fourth author: Department of Plant Pathology, North Carolina State University, Raleigh 27695; and sixth author: Department of Plant Pathology, Physiology & Weed Science, Virginia Polytechnic Institute & State University, Blacksburg 24061.
Go to article:
Accepted for publication 29 January 2011.
Transgenic peanut lines expressing oxalate oxidase, a novel enzyme to peanut, were evaluated for resistance to Sclerotinia blight in naturally infested fields over a 5-year period. Area under the disease progress curve (AUDPC) for transgenic lines in single rows planted with seed from single-plant selections averaged 78, 83, and 90% lower than nontransgenic parents in 2004, 2005, and 2006, respectively. In addition, AUDPC in 14 transgenic lines planted with bulked seed in two-row plots averaged 81% lower compared with nontransgenic parents in 2005 and 86% lower in 16 transgenic lines in 2006. Six transgenic lines yielded 488 to 1,260 kg/ha greater than nontransgenic parents in 2005, and 10 lines yielded 537 to 2,490 kg/ha greater in 2006. Fluazinam (0.58 kg a.i./ha) fungicide sprays in 2008 and 2009 reduced AUDPC in transgenic and nontransgenic lines but AUDPC was lowest in transgenic lines. Without fluazinam, yields of transgenic lines averaged 1,133 to 1,578 kg/ha greater than nontransgenic lines in 2008 and 1,670 to 2,755 kg/ha greater in 2009. These results demonstrated that the insertion of barley oxalate oxidase in peanut conveyed a high level of resistance to Sclerotinia blight, and negated the need for costly fungicide sprays.
Arachis hypogaea, disease resistance, oxalic acid, Sclerotinia minor.
© 2011 The American Phytopathological Society